Publicaciones
-
Calderon-Mediavilla M, Vila R, Dolz M, Butjosa A, Barajas A, del Cacho N, Sánchez Fernández B, Pardo M, Baños I, Usall J, GENIPE Group, PROFEP Group and Ochoa S.
Depressive symptoms and their relationship with negative and other psychotic symptoms in early onset psychosis.
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY . 30(9): 1383-1390. Nº de citas: 16
-
del Cacho N, Vila R, Butjosa A, Cuadras-Palleja D, Rubio E, MARIA JOSÉ RODRÍGUEZ MONTES, Muñoz D, Dolz M, PROFEP group and Usall J.
Sexual dysfunction in drug- naïve first episode nonaffective psychosis patients. Relationship with prolactin and psychotic symptoms. Gender differences.
PSYCHIATRY RESEARCH . 289: 112985-112985. Nº de citas: 11
-
del Cacho N, Butjosa A, Vila R, Cuadras-Palleja D, Kaplan M, Rubio E, Pardo M, Muñoz D, Cuevas-Esteban J, GERARDO SAENZ DE NAVARRETE RIBERA, PROFEP group and Usall J.
Prolactin levels in drug-naive first episode nonaffective psychosis patients compared with healthy controls. Sex differences
PSYCHIATRY RESEARCH . 276: 218-222. Nº de citas: 16
-
Alonso-Solís A, Rubinstein K, Corripio I, Jaaskelainen E, Seppälä A, Vella VA, Caro-Mendivelso J, Caspi A, Isohanni M, Unoka Z, Van der Graff S, Farkas K, Huerta-Ramos ME, Marcó-García S, Stevens M, Coenen T, Hospedales M, Berdún J, m-Resist group and Grasa EM.
Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST): a prospective multicentre feasibility study protocol in patients and their caregivers.
BMJ Open . 8(7): . Nº de citas: 9
-
Huerta-Ramos ME, Marcó-García S, Escobar-Villegas MS, Rubio E, Ochoa S, Grasa Bello EM, Alonso Solís A, Rabella M, Berdun J, Hospedales M, M-Resist G, Corripio I and Usall J.
m-RESIST, a complete m-Health solution for patients with treatmentresistant schizophrenia: a qualitative study of user needs and acceptability in the Barcelona metropolitan area.
ACTAS ESPANOLAS DE PSIQUIATRIA . 45(6): 277-289. Nº de citas: 7
-
Labad J, Martorell L, Huerta-Ramos ME, Cobo J, Vilella E, Rubio E, Garcia-Pares G, Creus M, Nuñez C, Ortega L, Miquel E, RALOPSYCAT Group and Usall J.
Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology . 26(10): 1683-1689. Nº de citas: 22
-
Rubio E, del Cacho N, Saenz-Navarrete G, Arranz B, Cambra RM, Cuadras-Palleja D, Rodante D, Fehér C, Roca M, Barneda V, Usall J and PROLACT Group.
How Hyperprolactinemia Affects Sexual Function in Patients Under Antipsychotic Treatment
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY . 36(5): 422-428. Nº de citas: 22
-
Rubio E, Usall J, Barajas A, Carlson J, Iniesta R, Huerta-Ramos ME, Baños I, Dolz M, Sánchez B and Ochoa S.
Relationship between menarche and psychosis onset in women with first episode of psychosis
Early Intervention in Psychiatry . 10(5): 419-425. Nº de citas: 4
-
Grau N, Rubio E, Usall J, Barajas A, Butjosa A, Dolz M, Baños I, Sánchez Fernández B, Rodríguez MJ, Peláez T, Sammut S, Carlson J, Huerta-Ramos ME, GENIPE Group and Ochoa S.
Influence of cognition, premorbid adjustment and psychotic symptoms on psycho-social functioning in first-episode psychosis
PSYCHIATRY RESEARCH . 242: 157-162. Nº de citas: 22
-
Huerta-Ramos ME, Escobar-Villegas MS, Rubinstein K, Unoka ZS, Grasa E, Hospedales M, Jääskeläinen E, Rubio E, Caspi A, Bitter I, Berdun J, Seppälä J, Ochoa S, Fazekas K, M-RESIST Group, Corripio I and Usall J.
Measuring Users' Receptivity Toward an Integral Intervention Model Based on mHealth Solutions for Patients With Treatment-Resistant Schizophrenia (m-RESIST): A Qualitative Study
JMIR mHealth and uHealth . 4(3): . Nº de citas: 20
